The Kids’ Cancer Project were front and centre at the SCG when the Sydney Swans hosted Port Adelaide.
To celebrate 30 years of partnership between the Swans and QBE, The Kids’ Cancer Project logo was proudly on display while the players prepared for their Round 20 match.
Ahead of their clash with the Power, Sydney Swans players warmed-up in special t-shirts featuring the logos of 11 different charities as well as the number 30 on the back. The t-shirts were signed and auctioned to help raise vital funds.
QBE Australia Chief Executive Officer Tim Plant said the campaign was about recognising the important work done by those who do so much to support the community.
“QBE’s 30-year partnership with the Sydney Swans has put QBE front and centre at every Swans game,” Plant said.
“In QBE’s Week of Giving we wanted to celebrate our partnership by showcasing our charity partners, as well as raise some important funds along the way."
“The charity runout t-shirts were worn by Swans players during the warm-up as well as for the much-anticipated traditional curtain-raiser between the Sydney Swans Legends and QBE brokers," he said.
The SCG big screens were also used to help raise awareness of all organisations involved and showcase the important work they do.
Sydney Swans Managing Director and CEO Andrew Ireland said the Swans are excited to help QBE give back to the community.
“QBE has been part of our Sydney Swans family for the past 30 years. It’s a wonderful milestone that we’re looking forward to celebrating in Round 20 at the SCG,” Ireland said.
"For QBE to use this match to highlight the work of charities speak volumes about the kind of organisation QBE is – they’ve supported us for 30 years and also give to the community through their Foundation and charity work. We’re really looking forward to being part of QBE’s Week of Giving.”
QBE's Week of Giving recognises the following charity partners
QBE Foundation partners:
Sydney Swans charity partners:
Donate to research and help find more effective treatments for kids with cancer.